Monthly
US$200
Billed every month
Sign in to subscribeCetrorelix Acetate for Injection
As of 13 November 2026, for Cetrorelix Acetate for Injection, 4 applications are listed as under review at China's CDE; 2 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 18 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 2 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders18View records ↓
Under-review filings4View records ↓
This year’s generic filers2View records ↓
NHSA approval numbers16View records ↓
API companies with A status12View records ↓
Chemical-drug catalogue
Loaded records: 18 holders; 1 in the quality-and-efficacy consistency-evaluation category, and 16 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Shanxi Wei Qi Da Guang Ming Pharmaceutical Co., Ltd. romanized | Shanxi Wei Qi Da Guang Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20265901 | 2026/09/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20265746 | 2026/08/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Suzhou Tian Ma Pharmaceuticals Group Tian Ji Biopharmaceutical Co., Ltd. romanized | Suzhou Tian Ma Pharmaceuticals Group Tian Ji Biopharmaceutical Co., Ltd. romanized | 国药准字H20265766 | 2026/08/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Changzhou Si Yao Pharmaceutical Co., Ltd. romanized | Changzhou Si Yao Pharmaceutical Co., Ltd. romanized | 国药准字H20264945 | 2026/06/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Hai Chen Pharma Co., Ltd. romanized | Nanjing Hai Chen Pharma Co., Ltd. romanized | 国药准字H20264796 | 2026/06/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Wuhan Ren Fu Li Kang Pharma Co., Ltd. romanized | Fujian Ji Nuo Hou Pu Bio Technology Co., Ltd. romanized | 国药准字H20263806 | 2026/03/31 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Hai Rong Pharmaceutical Co., Ltd. romanized | Jiangsu Li Tai Er Pharma Co., Ltd. romanized | 国药准字H20263289 | 2026/02/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Yang Zi Jiang Pharma Group Guangzhou Hai Rui Pharma Co., Ltd. romanized | Yang Zi Jiang Pharma Group Guangzhou Hai Rui Pharma Co., Ltd. romanized | 国药准字H20255711 | 2025/10/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | 国药准字H20254895 | 2025/07/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Kang Zhou Pharmaceuticals Technology Co., Ltd. romanized | Changzhou Qian Hong Sheng Hua Pharmaceutical Co., Ltd. romanized | 国药准字H20254056 | 2025/04/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Kai Feng Ming Ren Pharma Co., Ltd. romanized | Kai Feng Ming Ren Pharma Co., Ltd. romanized | 国药准字H20244760 | 2024/08/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20243480 | 2024/04/11 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Zhong He Pharma Co., Ltd. romanized | Hainan Zhong He Pharma Co., Ltd. romanized | 国药准字H20234144 | 2023/09/12 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hui Ling Pharmaceutical (Zhongguo) Co., Ltd. romanized | Shenzhen Han Yu Pharma Co., Ltd. romanized | 国药准字H20183468 | 2023/07/10 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Hainan Tian Sheng Bao He Bio Technology Co., Ltd. romanized | HAINAN HUALON PHARMACEUTICAL CO.,LTD | 国药准字H20233630 | 2023/05/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Changchun Jin Sai Pharma Co., Ltd. romanized | Changchun Jin Sai Pharma Co., Ltd. romanized | 国药准字H20223913 | 2022/11/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Li Zhu Group Li Zhu Pharmaceutical Factory romanized | Nanjing Jian You Sheng Hua Pharmaceutical Co., Ltd. romanized | 国药准字H20213977 | 2021/12/31 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Merck Europe B.V. | Pierre Fabre Medicament Production, Aquitaine Pharm International | H20140476 | 2005/02/21 | See source | Imported originator drug | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 16 distinct approval numbers and 16 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Yang Zi Jiang Pharma Group Guangzhou Hai Rui Pharma Co., Ltd. romanized | 国药准字H20255711 | See source | Not stated by source | XH01CCX013B001010100568 | NHSA |
| Changzhou Si Yao Pharmaceutical Co., Ltd. romanized | 国药准字H20264945 | See source | Not stated by source | XH01CCX013B001010101389 | NHSA |
| Nanjing Hai Chen Pharma Co., Ltd. romanized | 国药准字H20264796 | See source | Not stated by source | XH01CCX013B001010101563 | NHSA |
| Shanxi Wei Qi Da Guang Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20265901 | See source | Not stated by source | XH01CCX013B001010102841 | NHSA |
| Changchun Jin Sai Pharma Co., Ltd. romanized | 国药准字H20223913 | See source | Not stated by source | XH01CCX013B001010103315 | NHSA |
| Qilu Pharmaceutical Co., Ltd. | 国药准字H20243480 | See source | Not stated by source | XH01CCX013B001010104021 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20265746 | See source | Not stated by source | XH01CCX013B001010104188 | NHSA |
| Hainan Zhong He Pharma Co., Ltd. romanized | 国药准字H20234144 | See source | Not stated by source | XH01CCX013B001010105842 | NHSA |
| Kai Feng Ming Ren Pharma Co., Ltd. romanized | 国药准字H20244760 | See source | Not stated by source | XH01CCX013B001010107462 | NHSA |
| Merck (Schweiz) AG | 国药准字HJ20140476 | See source | Not stated by source | XH01CCX013B001010178860 | NHSA |
| Hui Ling Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H20183468 | See source | Not stated by source | XH01CCX013B001010179260 | NHSA |
| Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | 国药准字H20254895 | See source | Not stated by source | XH01CCX013B001010180539 | NHSA |
| Wuhan Ren Fu Li Kang Pharma Co., Ltd. romanized | 国药准字H20263806 | See source | Not stated by source | XH01CCX013B001010181917 | NHSA |
| Hainan Tian Sheng Bao He Bio Technology Co., Ltd. romanized | 国药准字H20233630 | See source | Not stated by source | XH01CCX013B001010183116 | NHSA |
| Nanjing Kang Zhou Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254056 | See source | Not stated by source | XH01CCX013B001010183233 | NHSA |
| Li Zhu Group Li Zhu Pharmaceutical Factory romanized | 国药准字H20213977 | See source | Not stated by source | XH01CCX013B001010201570 | NHSA |
| Hainan Zhong He Pharma Co., Ltd. romanized | 国药准字H20234144 | See source | Not stated by source | XH01CCX013B001010205842 | NHSA |
| Merck (Schweiz) AG | 国药准字HJ20140476 | See source | Not stated by source | XH01CCX013B001010278860 | NHSA |
| Hui Ling Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H20183468 | See source | Not stated by source | XH01CCX013B001010279260 | NHSA |
| Hainan Tian Sheng Bao He Bio Technology Co., Ltd. romanized | 国药准字H20233630 | See source | Not stated by source | XH01CCX013B001010283116 | NHSA |
| Li Zhu Group Li Zhu Pharmaceutical Factory romanized | 国药准字H20213977 | See source | Not stated by source | XH01CCX013B001010301570 | NHSA |
| Hui Ling Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H20183468 | See source | Not stated by source | XH01CCX013B001010379260 | NHSA |
| Li Zhu Group Li Zhu Pharmaceutical Factory romanized | 国药准字H20213977 | See source | Not stated by source | XH01CCX013B001010401570 | NHSA |
| Li Zhu Group Li Zhu Pharmaceutical Factory romanized | 国药准字H20213977 | See source | Not stated by source | XH01CCX013B001010501570 | NHSA |
| Li Zhu Group Li Zhu Pharmaceutical Factory romanized | 国药准字H20213977 | See source | Not stated by source | XH01CCX013B001010601570 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 4 filings and 4 distinct first applicants.
Generic 4
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Anhui An Ke Bio Gong Cheng (Group) Co., Ltd. romanized | CYHS2602026 | Generic | 2026/08/17 | Not stated by source | CDE |
| Beijing SL Pharmaceutical Co., Ltd. | CYHS2504311 | Generic | 2025/12/18 | Not stated by source | CDE |
| Zhejiang Zhong Yan Pharmaceuticals Technology Co., Ltd. romanized; Shuang He Pharma (Hainan) Co., Ltd. romanized | CYHS2500614 | Generic | 2025/02/07 | Not stated by source | CDE |
| Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CYHS2602620 | Generic | 2026/10/26 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 2 filings and 2 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Anhui An Ke Bio Gong Cheng (Group) Co., Ltd. romanized | CYHS2602026 | Generic | 2026/08/17 | Not stated by source | CDE |
| Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CYHS2602620 | Generic | 2026/10/26 | Not stated by source | CDE |
API registrations
Non-component matches: 12 companies with A status and 3 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 醋酸西曲瑞克 · No verified English name | Yang Zi Jiang Pharma Group Jiangsu Hai Ci Bio Pharma Co., Ltd. romanized | Y20260000749 | I | Exact ingredient | 2026/08/27 | CDE |
| 醋酸西曲瑞克 · No verified English name | BCN PEPTIDES, SA | Y20240001059 | I | Exact ingredient | 2025/01/15 | CDE |
| 醋酸西曲瑞克 · No verified English name | Shanxi Tong Da Pharma Co., Ltd. romanized | Y20240000543 | A | Exact ingredient | 2026/01/28 | CDE |
| 醋酸西曲瑞克 · No verified English name | Nanjing Hai Rong Pharmaceutical Co., Ltd. romanized | Y20230001331 | A | Exact ingredient | 2025/08/22 | CDE |
| 醋酸西曲瑞克 · No verified English name | Suzhou Tian Ma Pharmaceuticals Group Tian Ji Biopharmaceutical Co., Ltd. romanized | Y20230000378 | A | Exact ingredient | 2024/12/07 | CDE |
| 醋酸西曲瑞克 · No verified English name | Kai Feng Ming Ren Pharma Co., Ltd. romanized | Y20220000773 | A | Exact ingredient | 2024/08/20 | CDE |
| 醋酸西曲瑞克 · No verified English name | Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | Y20220000567 | A | Exact ingredient | 2024/06/06 | CDE |
| 醋酸西曲瑞克 · No verified English name | Shanghai Su Hao Yi Ming Pharmaceutical Co., Ltd. romanized | Y20220000449 | A | Exact ingredient | 2024/10/26 | CDE |
| 醋酸西曲瑞克 · No verified English name | Chengdu Sheng Nuo Biopharmaceutical Co., Ltd. romanized | Y20220000342 | A | Exact ingredient | 2024/02/23 | CDE |
| 醋酸西曲瑞克 · No verified English name | Han Yu Pharma (Wuhan) Co., Ltd. romanized | Y20220000234 | A | Exact ingredient | 2026/10/14 | CDE |
| 醋酸西曲瑞克 · No verified English name | Hainan Zhong He Pharma Co., Ltd. romanized | Y20210001264 | A | Exact ingredient | 2024/06/06 | CDE |
| 醋酸西曲瑞克 · No verified English name | Haerbin Ji Xiang Long Bio Technology Co., Ltd. romanized | Y20210000112 | A | Exact ingredient | 2024/01/17 | CDE |
| 醋酸西曲瑞克 · No verified English name | Zhong Tai Sheng Hua Co., Ltd. romanized | Y20190001147 | A | Exact ingredient | 2026/07/03 | CDE |
| 醋酸西曲瑞克 · No verified English name | Kai Feng Ming Ren Pharma Co., Ltd. romanized | Y20170000653 | I | Exact ingredient | — | CDE |
| 醋酸西曲瑞克 · No verified English name | Shenzhen Han Yu Pharma Co., Ltd. romanized | Y20170000279 | A | Exact ingredient | 2022/09/27 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/10/26Accepted
Nanjing Hai Na Pharmaceutical Co., Ltd. romanized
CYHS2602620
Fact date: 2026/10/26 · Site observation date: 2026/10/27
View source ↗ -
2026/08/17Accepted
Anhui An Ke Bio Gong Cheng (Group) Co., Ltd. romanized
CYHS2602026
Fact date: 2026/08/17 · Site observation date: 2026/10/22
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Cetrorelix Acetate for Injection
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy